These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
9. Rickettsial diseases and Rocky Mountain spotted fever--Part I. Riley HD Curr Probl Pediatr; 1981 Mar; 11(5):1-46. PubMed ID: 7016456 [No Abstract] [Full Text] [Related]
10. New assay of protective activity of Rocky Mountain spotted fever vaccines. Anacker RL; Smith RF; Mann RE; Hamilton MA J Clin Microbiol; 1976 Sep; 4(3):309-11. PubMed ID: 823177 [TBL] [Abstract][Full Text] [Related]
11. Preparation of Rocky Mountain spotted fever vaccine suitable for human immunization. Kenyon RH; Pedersen CE J Clin Microbiol; 1975 Jun; 1(6):500-3. PubMed ID: 809483 [TBL] [Abstract][Full Text] [Related]
12. Rocky Mountain spotted fever acquired in a laboratory. Johnson JE; Kadull PJ N Engl J Med; 1967 Oct; 277(16):842-7. PubMed ID: 6046683 [No Abstract] [Full Text] [Related]
14. Rickettsial vaccines: the old and the new. Richards AL Expert Rev Vaccines; 2004 Oct; 3(5):541-55. PubMed ID: 15485334 [TBL] [Abstract][Full Text] [Related]
16. Comparison of the immunogenic and anaphylactogenic properties of Rocky Mountain spotted fever vaccines prepared from infected yolk sacs and from infected tick tissue. LACKMAN D; PARKER RR Am J Public Health Nations Health; 1948 Oct; 38(10):1402-4. PubMed ID: 18887591 [No Abstract] [Full Text] [Related]
18. The epidemiology and control of Rocky Mountain spotted fever. Zaki MH N Y State J Med; 1984 Feb; 84(2):62-3. PubMed ID: 6583557 [No Abstract] [Full Text] [Related]